Disclosed herein are compounds and methods for inhibiting Aha1 for the treatment of tauopathies and neurodegenerative diseases. The Aha1 inhibitor may reduce the interaction between Aha1 and Hsp90. The Aha1 inhibitor may reduce aggregation of tau protein. The Aha1 inhibitor may include a compound selected from KU-177, KU-174, and KU-308.
本文公开了抑制 Aha1 的化合物和方法,用于治疗牛头蛋白病和神经退行性疾病。Aha1
抑制剂可减少 Aha1 与 Hsp90 之间的相互作用。Aha1
抑制剂可减少 tau 蛋白的聚集。Aha1
抑制剂可包括选自KU-177、KU-174和KU-308的化合物。